Abiopharma

🔍 Sullivan Adam Taylor (Executive)

Company: Core Scientific, Inc./tx (CORZ)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 741,545 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 4,872,695.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 315,307 shares of Common Stock at $14.96 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: false | shares_owned_after: 4,557,388.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents a performance-based restricted stock unit ("PSU") grant. The Reporting Person was granted PSUs on April 28, 2025 that vest based on the satisfaction of specified performance criteria, provided that the Reporting Person continues to provide service to the Issuer through the end of the applicable measurement period. Effective as of March 31, 2026, in accordance with the terms of the applicable PSUs, the Compensation Committee of the Board of Directors of the Issuer certified the level of satisfaction of the applicable prescribed performance criteria and approved the settlement of such PSUs.
• F2: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.